Nathalie Galicia

Nathalie Galicia supports the procurement mission of the Naval Medical Research Unit South (N44852), a Department of the Navy research facility focused on advancing military medical readiness through applied science in tropical and infectious diseases. In her capacity, she manages acquisitions for specialized laboratory equipment, diagnostic reagents, and field-deployable analytical systems critical to biothreat detection and entomological surveillance. Her work ensures that expeditionary medical forces have access to cutting-edge, mission-critical technologies tailored to high-risk operational environments, aligning procurement activities with the agency’s strategic priorities in diagnostics, vector-borne threat mitigation, and rapid-response health surveillance. Galicia collaborates with a diverse set of vendors, including manufacturers of analytical laboratory instruments, in-vitro diagnostic substance producers, and medical wholesale distributors. Her contracting patterns reflect a preference for technically sophisticated suppliers capable of delivering validated, FDA-regulated, or military-specification-compliant products. While no single contractor dominates her portfolio, she consistently engages firms with demonstrated expertise in biosafety-compliant manufacturing and rapid prototyping of deployable diagnostic tools, fostering partnerships that prioritize reliability, regulatory compliance, and supply chain resilience. Her procurement strategy reflects a strong emphasis on open competition, with 75% of acquisitions conducted without set-asides, yet she maintains a deliberate 25% allocation to 8(a) certified small businesses. This balance ensures access to innovative small firms while preserving competition for high-complexity technical requirements. Her approach demonstrates a strategic commitment to socioeconomic goals without compromising mission-critical performance standards. Galicia’s primary NAICS focus areas include analytical laboratory instrument manufacturing, in-vitro diagnostic substance production, and electronic computer manufacturing—reflecting her specialization in procuring precision diagnostic systems, molecular testing kits, and ruggedized field-deployable computing platforms. Her domain expertise lies at the intersection of biomedical engineering, public health surveillance, and defense medical logistics, ensuring acquisitions directly enable the unit’s mission to protect naval forces from region-specific infectious disease threats.